Annalisa Chiappella, MD¹, Anna Dodero, MD^2*, Andrea Evangelista, MSc^3*, Alessandro Re, MD^4*, Lorella Orsucci, MD^5*, Sara Veronica Usai^6*, Claudia Castellino^7*, Vittorio Stefoni, MD^8*, Antonio Pinto^9*, Manuela Zanni, MD^10*, Rosanna Ciancia^11*, Chiara Ghiggi^12*, Francesca Gaia Rossi^13*, Annalisa Arcari, MD^14*, Fiorella Ilariucci^15*, Vittorio Ruggero Zilioli, MD^16*, Leonardo Flenghi^17*, Melania Celli^18*, Stefano Volpetti^19*, Fabio Benedetti, MD^20*, Filippo Ballerini^21*, Gerardo Musuraca^22*, Riccardo Bruna^23*, Caterina Patti^24*, Francesco Leonardi^25*, Luca Arcaini, MD^26*, Massimo Magagnoli, MD^27*, Federica Cavallo, MD^28*, Valentina Tabanelli, PhD^29*, Giovannino Ciccone, MD, PhD^30*, Stefano A Pileri³¹ and Paolo Corradini, MD³²

¹Division of Hematology & Stem Cell Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Milano, Italy
²Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
³Unit of Clinical Epidemiology, Città della Salute e della Scienza di Torino, Torino, Italy
⁴Department of Hematology, ASST Spedali Civili, Brescia, ID, Italy
⁵Hematology, Città della Salute Hospital and University, Torino, Italy
⁶Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy
⁷Division of Hematology, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
⁸Hematology, Department of Translational and Precision Medicine, Università di Bologna, Bologna, Italy
⁹Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Hematology and Innovative Therapies, National Cancer Institute, Fondazione 'G. Pascale', IRCCS, Naples, Italy
¹⁰Division of Hematology, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
¹¹Onco-hematology and Stem Cell Transplantation and Cellular Therapies, Centro di Riferimento Oncologico (CRO) IRCCS, Aviano, Italy
¹²Hematology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
¹³Division of Hematology, Fondazione IRCCS Cà Granda, OM Policlinico, Milano, Italy
¹⁴Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
¹⁵Azienda Ausl IRCCS Santa Maria Nuova Reggio Emilia, Reggio Emilia, Italy
¹⁶Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
¹⁷Hematology, S. Maria della Misericordia Hospital, Perugia, Italy
¹⁸U.O. di Ematologia, Ospedale degli Infermi di Rimini, Rimini, Italy
¹⁹Clinic of Hematology, Presidio Ospedaliero Universitario "Santa Maria della Misericordia” di Udine, ASUFC, Udine, Italy
²⁰Hematology and Stem Cell Transplantation, Azienda Ospedaliera Universitaria di Verona, Verona, Italy
²¹IRCCS Ospedale Policlinico San Martino, Clinic of Hematology, Department of Internal Medicine (DiMI), Genova, Italy
²²Division of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
²³Division of Hematology, Ospedale Maggiore Della Carità, Novara, Italy
²⁴Division of Onco-Hematology, Azienda Villa Sofia Cervello, Palermo, Italy
²⁵Hematology and CTMO, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy
²⁶Division of Hematology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy
²⁷Hematology, IRCCS Humanitas Research Hospital, Rozzano-Milano, Italy
²⁸Division of Hematology , AOU Città della Salute e della Scienza di Torino, Torino, Italy
²⁹Division of Diagnostic Haematopathology, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy
³⁰Unit of Cancer Epidemiology, CPO Piemonte, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
³¹Hematopathology Division, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy
³²University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Nathalie A. Johnson, MD, PhD,¹, David Lavie, MD^2*, Peter Borchmann³, Gareth P. Gregory, MBBS, PhD, FRACP, FRCPA⁴, Alex F. Herrera, MD⁵, Leonard Minuk, MD, FRCPC⁶, Vladan Vucinic, MD^7*, Philippe Armand, MD, PhD⁸, Abraham Avigdor, MD⁹, Robin Gasiorowski, MA, FRACP, FRCPA, MBBS¹⁰, Yair Herishanu, MD^11*, Colm Keane, MB, BCh, BAO, MRCPI, MSc, MBA, FRCPath, PhD^12*, John Kuruvilla, MD¹³, John Palcza^14*, Pallavi Pillai^14*, Akash Nahar, MD, MPH^14* and John Timmerman, MD¹⁵

¹Jewish General Hospital, Montreal, QC, Canada
²Hadassah Medical Center, Jerusalem, Israel
³U. klinikum Koeln AOER, Cologne, Germany
⁴School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia
⁵City of Hope, Duarte, CA
⁶CancerCare Manitoba and University of Manitoba, Winnipeg, MB, Canada
⁷Leipzig University Medical Center, Clinic and Policlinic for Hematology, Celltherapy and Hemostaseology, Leipzig, Germany
⁸Dana-Farber Cancer Institute, Boston, MA
⁹Chaim Sheba Medical Center, Ramat Gan, Israel
¹⁰Concord Hospital, University of Sydney, Concord, NSW, Australia
¹¹Sourasky Medical Center, Tel Aviv-Yafo, Israel
¹²Princess Alexandra Hospital, Brisbane, QLD, Australia
¹³Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁴Merck & Co., Inc., Rahway, NJ
¹⁵UCLA Medical Center, Los Angeles, CA

Stefan K. Barta, MD¹, Tatyana A. Feldman, MD², Jennifer A. DeSimone, MD^3*, Ellen Kim^4*, Karthik Devajaran, PhD^5*, Yibin Yang^6*, Henry C. Fung, FRCP, MBBChir⁷, Tafseer Mahvish, MD^8*, Shazia Nakhoda, MD⁹ and Nadia Khan, MD¹⁰

¹Abramson Cancer Center, Lymphoma Program, University of Pennsylvania, Philadelphia, PA
²John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
³Melanoma and Skin Oncology Center, INOVA, Fairfax, VA
⁴University of Pennsylvania School of Medicine, Philadelphia, PA
⁵The Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Phladelphia
⁶Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia
⁷Fox Chase Cancer Center, Temple Health, Philadelphia, PA
⁸Investigator Sponsored Research Unit (ISRU), Fox Chase Cancer Center, Philadelphia
⁹Malignant Hematology, Fox Chase Cancer Center, Philadelphia, PA
¹⁰Fox Chase Cancer Center, Philadelphia, PA

Yuqin Song, MD¹, Won-Seog Kim, MD, PhD^2*, Dok-Hyun Yoon, MD, PhD^3*, Haiyan Yang^4*, Junning Cao, MD⁵, Dongmei Ji^5*, Youngil Koh, MD, PhD⁶, Hongmei Jing⁷, Hyeon-Seok Eom^8*, Jae-Yong Kwak, MD, PhD⁹, Won-Sik Lee, MD, PhD¹⁰, Jong-Seok Lee^11*, Ho-Jin Shin^12*, Jie Jin, PhD¹³, Mei Wang^14*, Jingrun Li, MD, PhD^14* and Jun Zhu, PhD¹⁵

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
²Hematology and Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
³Department of Oncology, Hematologic Cancer & BMT center, Asan Medical Center, Seoul, Korea, Republic of (South)
⁴Department of lymphoma, Zhejiang Cancer Hospital, Hangzhou, China
⁵Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
⁶Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁷Department of Hematology, Peking University Third Hospital, Beijing, China
⁸Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea, Republic of (South)
⁹Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea, Republic of (South)
¹⁰Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
¹¹Division of Hematology & Medical Oncology, Seoul National University Bundang Hospital, Seoul, Korea, Republic of (South)
¹²Division of Hematology-Oncology, Department of Internal Medicine, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea, Republic of (South)
¹³Department of Hematology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
¹⁴Dizal Pharmaceuticals, Shanghai, China
¹⁵Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

Ryan C. Lynch, MD¹, Stefan K. Alig, MD², Chaitra S. Ujjani, MD³, Christina Poh, MD¹, Edus H. Warren, MD, PhD⁴, Stephen D. Smith, MD⁵, Mazyar Shadman, MD⁶, Andrei Shustov, MD¹, Brian G. Till, MD⁷, Vikram Raghunathan, MD^1*, Yolanda D. Tseng, MD^8*, Hilary Coye, PA-C^9*, Megan Shelby, PA-C^9*, Susan Ottemiller, ARNP, DNP^9*, Sarith Keo, PA-C^9*, Kaitlin Verni, PA-C^9*, Hongyan Du, MD^10*, Jacquelin Vandermeer, BS^11*, Ashley Gaston, BS, MA^9*, Heather A. Rasmussen^1*, Avanti Gulhane, MD^12*, Delphine Chen, MD^12*, Eric Wayne Dean, MD^13*, Paul S. Martin, MD¹⁴, Edmond A Marzbani, MD^10*, Jenna M. Voutsinas, MPH^7*, Ash A. Alizadeh, MD, PhD¹⁵ and Ajay K. Gopal, MD¹⁶

¹Division of Hematology and Medical Oncology, University of Washington, Seattle, WA
²Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
³Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁴Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
⁶University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
⁷Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁸Department of Radiation Oncology, University of Washington, Seattle
⁹Fred Hutchinson Cancer Center, Seattle, WA
¹⁰University of Washington, Seattle, WA
¹¹University of Washington, Seattle
¹²Department of Radiology, University of Washington, Seattle, WA
¹³Seattle Cancer Care Alliance, Seattle, WA
¹⁴Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
¹⁵Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA
¹⁶University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA

Susan K. Parsons, MD, MRCP^1,2, Frank G. Keller, M.D.³, Qinglin Pei, PhD^4*, Angie Mae Rodday, PhD⁵, Jennifer Belsky, DO, MS^6*, Yue Wu, MS^7*, Angela Punnett, MD^8*, Tara O Henderson, MD, MPH^9*, Kara M. Kelly, MD¹⁰ and Sharon M. Castellino, MD, MSc¹¹

¹Tufts Medical Center, Tufts Medical Center, Boston, MA
²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
³Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children's Healthcare of Atlanta, Atlanta, GA
⁴Children's Oncology Group Statistics & Data Center, Gainesville, FL
⁵Institute for Clinical Research & Health Policy Studies, Tufts Medical Center, Boston, MA
⁶Cancer and Blood Diseases Institute, Riley Hospital for Children | Indiana University School of Medicine, Indianapolis,, IN
⁷Children’s Oncology Group Statistics & Data Center, Gainesville, FL
⁸Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
⁹Section of Hematology, Oncology, and Stem Cell Transplantation, University of Chicago Comer Children's Hospital, Chicago, IL
¹⁰Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹¹Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA

Eric Mou, MD^1,2, Sebastian Fernandez-Pol, MD, PhD^3*, Shufeng Li^4,5*, Youn H. Kim, MD⁴ and Michael S. Khodadoust, MD PhD^2,6

¹Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
²Division of Oncology, Stanford University School of Medicine, Palo Alto, CA
³Department of Pathology, Stanford University School of Medicine, Stanford, CA
⁴Department of Dermatology, Stanford University School of Medicine, Palo Alto, CA
⁵Department of Urology, Stanford University School of Medicine, Palo Alto, CA
⁶Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA

Huiqiang Huang, MD, PhD¹, Yan Gao, MD, PhD^1*, Huilai Zhang^2*, Keshu Zhou^3*, Jianqiu Wu, MD^4*, Zhen Cai, PhD, MD^5*, Hongmei Jing⁶, LEI Fan, MD^7,8*, Sai Lou, PhD^9*, Yizhou Fei, MS^9*, Aihua Wang, PhD^9* and Kevin Lynch, MB BS^9*

¹Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
³Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
⁴Department of Medical Oncology, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, AL, China
⁵Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
⁶Department of Hematology, Peking University Third Hospital, Beijing, China
⁷Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
⁸Department of Hematology, Pukou CLL Center, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China, Nanjing, Ji, China
⁹Antengene Therapeutics Ltd., Shanghai, China

Robert Stuver, MD¹, Paola Ghione, MD², Nivetha Ganesan, MPH^1*, Sarah Noor, MD^3*, Brandon S. Imber, MD⁴, Melissa Pulitzer, MD^5* and Steven M. Horwitz, MD¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Roswell Park Comprehensive Cancer Center, New York, NY
³Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Dermatopathology Service, Department of Pathology and Laboratory Medicine, New York

Maria Carmen Martinez Munoz, PhD^1*, Mariana Bastos-Oreiro, MD, PhD^2*, Ariane Boumendil^3*, Hervé Finel^4*, Ali Bazarbachi, MD, PhD⁵, Mohsen Alzahrani, MD^6*, Arpad Illes, MD^7*, Didier Blaise, MD, PhD⁸, Ioanna Sakellar^9*, Carlos Solano, MD, PhD^10*, Alessandro Pulsoni^11*, Tsila Zuckerman, MD¹², Nadira Durakovic^13*, Luca Castagna^14*, Simona Sica^15*, Stéphanie Guidez, MD^16*, Jean-Henri Bourhis, MD^17*, Ramon Garcia-Sanz¹⁸, Muhlis Cemm Ar^19*, Aspasia Stamatoulas Bastard, MD^20*, Javier Briones, MD, PhD^21*, Saad Aktar^22*, Ron Ram, MD^23*, Inmaculada Heras, MD, PhD^24*, Marie Thérèse Rubio, MD, PhD^25,26*, Mario Petrini²⁷, Mario Ojeda-Uribe^28*, Bertram Glass, MD^29* and Anna Sureda³⁰

¹Hematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
²Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
³Lymphoma Working Party Office, EBMT, Paris, France
⁴EBMT Lymphoma Working Party Paris Office, Paris, France
⁵American University of Beirut Dept. of Medicine, Beirut, Lebanon
⁶King-Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
⁷Faculty of Medicine, Department of Hematology, University of Debrecen, Debrecen, Hungary
⁸Hematology Department, Institut Paoli-Calmettes, Marseille, France
⁹George Papanicolaou General Hospital, Thessaloniki, Greece
¹⁰Hospital Clinico Universitario, University of Valencia, Valencia, Spain
¹¹Sapienza University of Rome, Rome, Italy
¹²Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
¹³University Hospital Center Zagreb, Zagreb, Croatia
¹⁴U.O.D Trapianti di midollo osseo, Palermo, Italy
¹⁵Universita Cattolica S. Cuore, Rome, Italy
¹⁶Hopital La Miletrie, Poitiers, France
¹⁷BMT Service, Department of Hematology, Institut Gustave Roussy, Villejuif, France
¹⁸Hospital Clínico Universitario, Salamanca, Spain
¹⁹Istanbul University-Cerrahpasa, Cerrahpasa, Turkey
²⁰Henri Becquerel Center, Rouen, France
²¹Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
²²Department of Medical Oncology, King Faisal Specialist Hospital and Research Cen, Riyadh, SAU
²³BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²⁴Hematology Department, Hospital Universitario Morales Meseguer, Murcia, Spain
²⁵IMoPa, University of Lorraine, Vandoeuvre, France
²⁶Service Hématologie, CHRU Brabois, Nancy, France
²⁷Azienda Ospedaliero Universitaria Pisana, Department of Clinical and Experimental Medicine, Hematology, Pisa, Italy
²⁸Department of Hematology and Cellular Therapy, GHRMSA, Mulhouse, France
²⁹Asklepios Hospital St Georg, Hamburg, Germany
³⁰Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain

Christina Poh, MD^1,2, Andrei Shustov, MD^1,2, Ivan J. Huang, PharmD^1,2*, Ajay K. Gopal, MD^1,2 and Stephen D. Smith, MD^1,2

¹Division of Hematology and Medical Oncology, University of Washington, Seattle, WA
²Fred Hutchinson Cancer Center, Seattle, WA

Ana C. Xavier, MD¹, Nader Kim El-Mallawany, MD^2*, Matt J. Ehrhardt, MD, MS³, Luciano J. Megala Costa, MD, PhD^4,5 and Mitchell S. Cairo, MD^6,7,8,9,10

¹University of Alabama at Birmingham, Birmingham, AL
²Section of Hematology/Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX
³Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN
⁴University of Alabama at Birmingham Hospital, Vestavia, AL
⁵O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
⁶Department of Pediatrics, New York Medical College, Valhalla, NY
⁷Departments of Microbiology & Immunology & Pathology, New York Medical College, Valhalla, NY
⁸Department of Medicine, New York Medical College, Valhalla, NY
⁹Immunology and Cell Therapy, New York Medical College, Valhalla, NY
¹⁰Department of Cell Biology & Anatomy, New York Medical College, Valhalla, NY

Cindy L Schwartz, MD¹, Qinglin Pei, PhD^2*, Frank G. Keller, M.D.³, Steve Y Cho, MD^4*, David C. Hodgson, MD, MPH, FRCPC^5*, Kathleen M McCarten, MD^6*, Yue Wu, MS^7*, Kara M. Kelly, MD⁸ and Sharon M. Castellino, MD, MSc⁹

¹Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
²Children's Oncology Group Statistics & Data Center, Gainesville, FL
³Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children's Healthcare of Atlanta, Atlanta, GA
⁴Wisconsin Institute for Medical Research, Madison, WI
⁵Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁶IROCRI, Lincoln, RI
⁷Children’s Oncology Group Statistics & Data Center, Gainesville, FL
⁸Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁹Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA

Chong Wei, MD^1*, Yan Zhang, MD^2*, Jian Li, MD³, Wei Zhang^4* and Daobin Zhou^5*

¹Peking Union Medical College Hospital， Chinese Academy of Medicine, Beijing, China
²Department of Hematology,, Peking Union Medical College Hospital, Beijing, China
³Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⁴Peking Union Medical College Hospital, Beijing, China
⁵Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Yumeng Zhang, MD¹, Ashley Rose, MD^2*, Jennifer Eatrides, MD³, Hayder Saeed, MD³, Bijal D. Shah, MD⁴, Aleksandr Lazaryan, MD, PhD, MPH⁵, Farhad Khimani, MD⁶, Javier Pinilla Ibarz, MD³, Hien D. Liu, MD⁷, Frederick L. Locke, MD⁸, Michael D. Jain, MD, PhD⁷, Mohamed A. Kharfan-Dabaja, MD, MBA⁹, Jongphil Kim, PhD^10*, Ling Zhang, MD^11*, Ernesto Ayala, MD¹², Taiga Nishihori, MD^7,8 and Lubomir Sokol, MD, PhD³

¹H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa
²H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴H. Lee Moffitt Cancer Center, Tampa, FL
⁵Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
⁷Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
⁸Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
¹⁰Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institutte, Tampa, FL
¹¹Department of Hematopathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹²Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL

Yu Uemura, MD, PhD^1*, Masahide Yamamoto, MD, PhD^2*, Masataka Ishimura, MD, PhD^3*, Hirokazu Kanegane, MD, PhD^4*, Akihisa Sawada, MD, PhD^5*, Akihiro Hirakawa, PhD^6*, Ken-Ichi Imadome, PhD^7*, Mayumi Yoshimori, PhD^8*, Masashi Nagata, PhD^9*, Norio Shimizu, PhD^10*, Ryuji Koike, MD, PhD^11* and Ayako Arai, MD, PhD^1,8

¹Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan
²Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
³Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
⁴Department of Child Health and Development, Tokyo Medical and Dental Universtiy (TMDU), Tokyo, JPN
⁵Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, Japan
⁶Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
⁷Department of Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan
⁸Department of Laboratory Molecular Genetics of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
⁹Department of Pharmacokinetics and Pharmacodynamics, Tokyo Medical and Dental University, Tokyo, Japan
¹⁰Center for Stem Cell and Regenerative Medicine, Division of Advanced Multidisciplinary Research, Tokyo Medical and Dental University, Tokyo, Japan
¹¹Medical Innovation Promotion Center, Tokyo Medical and Dental University Medical Hospital, Tokyo, JPN

Muhammad Salman Faisal, MD, MBBS¹, Gabrielle Hartman^2*, Arya Roy, MD^3*, Andrea Anampa-Guzman, MD^1*, Sheeba Ba Aqeel, MD⁴, Hassan Awada, MD^5*, Matthew J Cortese, MD, MPH¹, Pallawi Torka, MD⁶, Suchitra Sundaram, MD^1,7 and Paola Ghione, MD⁸

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Department of Medicine, Roswell Park Comprehensive Cancer Center, University At Buffalo, NY
³Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁵Roswell Park Comprehensive Cancer Center, Buffalo
⁶Roswell Park Cancer Center, Buffalo, NY
⁷Tisch Cancer Institute at Mount Sinai, New York, NY
⁸Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Tony Z. Zhuang, MD^1*, Ashley Alesia McCook, MPH^2*, Jeffrey M. Switchenko, PhD, MS^2*, Tim Niyogusaba, BA^1*, Erica Shantha Tarabadkar, MD^3*, Katelin Baird, BS^4*, Colin B. O'Leary, MA^4*, Darina Paulino, MS^4*, Mary Jo Lechowicz, MD⁴ and Pamela B. Allen, MD⁴

¹Department of Medicine, Emory University School of Medicine, Atlanta, GA
²Departments of Biostatistics and Bioinformatics, Emory University School of Medicine, Atlanta, GA
³Department of Dermatology, Emory University School of Medicine, Atlanta, GA
⁴Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

H. Miles Miles Prince, MD¹, Larisa J Geskin, MD^2*, Oleg E Akilov, MD^3*, Timothy M. Kuzel, MD⁴, Christiane Querfeld, MD, PhD⁵, Chean Eng Ooi, PhD^6*, Dongyuan Xing, PH D^6*, Nicholas Sauter, MD^6*, Preeti Singh, MD^7*, Myron Czuczman, MD⁸ and Francine M. Foss, MD⁹

¹Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
²Department of Dermatology, Columbia University Medical Center, New York City, NY
³Dept. of Dermatology, University of Pittsburgh, Pittsburgh, PA
⁴Division of Hematology, Oncology & Cell Therapy, Rush University Medical Center, Chicago, IL
⁵Division of Dermatology, City of Hope, Duarte, CA
⁶Eisai Inc., Nutley, NJ
⁷Citius Pharmaceuticals Inc., Yardley, PA
⁸Citius Pharmaceuticals Inc., Cranford, NJ
⁹Hematology, Yale Cancer Center, New Haven, CT

Shuang Zhao^1*, Yanyan Liu^2*, Zhihua Yao, MM^3*, Zheng Yan^4*, Shuna Yao^1*, Junfeng Chu^1*, Haiying Wang^1*, Jiuyang Zhang^1*, Peipei Zhang^1* and Wenping Zhou^1*

¹Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
²Affiliated Cancer Hospital of Zhengzhou University, zhengzhou, China
³Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, CHN
⁴Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

Chiara Rusconi^1*, Francesca Ricci, MD^2*, Vincenzo Marasco, MD^3*, Vittorio Ruggero Zilioli, MD^4*, Eleonora Calabretta, MD^5*, Anna Guidetti, MD^6,7, Cristina Muzi^8*, Federico Mazzon, MD^9*, Margherita Smania^9*, Martina Sollini, MD^10*, Sara Iadecola^11*, Erika Meli^12*, Marcello Rodari, MD^13*, Emanuele Ravano, MD^14*, Roberto Cairoli^15*, Paolo Corradini, MD^16,17 and Armando Santoro, MD^18,19*

¹Department of Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
²Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy
³Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy
⁴Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
⁵Department of Biomedical Sciences, Humanitas University, Milano, Italy
⁶Università di Milano, Milano, Italy
⁷Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
⁸ASST Grande Ospedale Metropolitano Niguarda, Milan, ITA
⁹University of Milan, Milan, Italy
¹⁰Department of Nuclear Medicine, Humanitas Clinical and Reseach Center IRCCS, Rozzano, Italy
¹¹Unit of Clinical Epidemiology and Trial Organization, Department of Applied Rese, Milan, ITA
¹²Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
¹³Nuclear Medicine, IRCCS Humanitas Research Hospital, Milano, Italy
¹⁴Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
¹⁵ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, MILANO, MI, Italy
¹⁶Universita' di Milano, Milano, Italy
¹⁷Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
¹⁸Department of Biomedical Sciences, Humanitas University, Milan, Italy
¹⁹Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy

Sushmitha Nanja Reddy, MBBS^1*, Abdul Moiz Khan, MBBS², Vikram Dhillon, DO^1*, Ali Al Sbihi, MD^1*, Amanda Tear^2*, Breanna William^2*, Sonubar Virk^2*, Julie Boerner^2* and Suresh Kumar Balasubramanian, MD^2,3

¹Department of Internal Medicine, Wayne State University, Detroit, MI
²Department of Oncology, Wayne State University/ Karmanos Cancer Institute, Detroit, MI
³Taussig Cancer Institute, Cleveland Clinic Foundation, Department of Translational Hematology and Oncology Research, Cleveland, OH

Fernanda Maria Maria Santos^1*, Jose Flavio Gomes Marin, M.D^2*, Marcos Santos Lima, M.D^2,3*, Wellington F Silva Jr., MD PhD^4,5, Rodrigo D Velasques, MD^3*, Ana Carolina Arrais Maia, MD^3,6*, Marcelo Junqueira Atanazio, MD^3,7*, Lucas Bassolli de Oliveira Alves, PhD^6*, Frederico Rafael Moreira, BS^7*, Carlos Alberto Buchpiguel, M.D, Ph.D^8*, Valeria Buccheri, PhD^6,9,10,11* and Vanderson Rocha, Prof, MD, PhD^11,12,13,14*

¹Instituto do Cancer de São Paulo (ICESP), University of Sao Paulo (USP), Sao Paulo, Brazil
²Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
³Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo, Brazil
⁴Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina, University of São Paulo (FMUSP), São Paulo, Brazil
⁵Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (HCFMUSP), São Paulo, Brazil
⁶Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas, Faculdade de Medicina, Universidade de Sao Paulo (HCFMUSP), São Paulo, Brazil
⁷Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas, Faculdade de Medicina, Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil
⁸Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clínicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
⁹Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), São Paulo, Brazil
¹⁰Laboratory of medical investigation in pathogenesis and targeted therapy in onco-immuno-hematology (LIM-31), Department of Internal Medicine, Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (HCFMUSP), São Paulo, Brazil
¹¹Department of Hematology, Churchill Hospital, NHS BT, Oxford University, Oxford, United Kingdom
¹²Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
¹³Medical Research Laboratory on Molecular Hematology (LIM-31), Universidade de São Paulo, São Paulo, Brazil
¹⁴Instituto do Cancer do Estado de São Paulo (ICESP), University of São Paulo (USP), São Paulo, Brazil

Olga Novosad, PhD, MD¹, Oleksandr Gorbach, PhD^2* and Oksana Skachkova, PhD^2*

¹Oncohematology, National Cancer Institute, Kyiv, Ukraine
²Experimental Oncology, National Cancer Institute, Kyiv, Ukraine

Marriam Mponda, MBBs^1*, Evaristar Kudowa, MPH^1*, Bongani Kaimila, MBBS^1*, Edwards Kasonkanji, MPH^1*, Noel Mumba, Dip Clin Med^1*, Lusayo Simwinga, MBBs^1*, Tamiwe Tomoka, MBBs^1*, Yuri Fedoriw, MD^1,2* and Matthew Painschab, MD^1,2

¹UNC Project Malawi, Lilongwe, Malawi
²Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

Sireecha Vutukuri, MD^1*, Frankie Powell, MD² and Philip A Haddad, MD²

¹Overton Brooks VAMC, Shreveport
²LSUHSC-S/Overton Brooks VAMC, Shreveport, LA

Dong Won Baek Sr., MD, PhD^1*, Je-Hwan Lee, MD, PhD², Ho Joon Im, MD^3*, Juhyung Kim, MD, PhD^4*, Joon Seong Park^5*, Deok-Hwan Yang, MD, PhD^6*, Sung-Hyun Kim, MD, PhD⁷, Yeung-Chul Mun, MD^8*, Jae Hoon Lee, MD, PhD⁹, Ho Sup Lee, MD¹⁰, Ka-Won Kang, MD, PhD^11*, Chuhl Joo Lyu, MD, PhD^12*, Seong Kyu Park, MD^13*, Jong Ho Won, MD, PhD¹⁴, Chul Won Jung, MD, PhD^15*, Keon Hee Yoo, MD^16*, Sung-Soo Yoon, MD, PhD¹⁷, Soo-Mee Bang, MD, PhD¹⁸, Jae-Cheol Jo, MD., PhD.¹⁹, Joon Ho Moon, MD²⁰ and Sang Kyun Sohn^21*

¹Hematology&Oncology, Kyungpook National University Hospital, Daegu, South Korea
²Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children’s Hospital, seoul, Korea, Republic of (South)
⁴Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, KOR
⁵Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
⁶Department of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Gwang-ju, Korea, Republic of (South)
⁷Dong-A University College of Medicine, Busan, Korea, Republic of (South)
⁸Department of Hematology, Ewha Womans University, Seoul, Korea, Republic of (South)
⁹Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
¹⁰Division of Hematology-Oncology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
¹¹Department of Internal Medicine, Korea University Guro Hospital, Seoul, Seoul, Korea, Republic of (South)
¹²Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
¹³Department of Hematology-Oncology, Soonchunhyang University Hospital, Seoul, Korea, Republic of (South)
¹⁴Department of Internal Medicine, Soonchunhyang University, Seoul, Korea, Republic of (South)
¹⁵Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
¹⁶Dep. of Pediatrics, Samsung Medical Center, Seoul, Korea, Republic of (South)
¹⁷Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹⁸Division of Hemato-Oncology, Department of Internal medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea
¹⁹Department of Hematology and Oncology,, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Republic of (South)
²⁰Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
²¹Kyungpook National University Hospital, Daegu, Korea, Republic of (South)